梁文青于2026年9月28日在联交所场内以每股均价7.2916港元买入长风药业(02652)H股2.51万股,涉资约18.30万港元,属场内主动交易,即在二级市场直接买卖股份。
梁文青此次增持前持有长风药业好仓6067.21万股,占比18.73%;增持后持股量为6069.72万股,好仓比例升至18.74%。
本次涉及关联方:苏州美中瑞投资管理企业(有限合伙)。
梁文青于2026年9月28日在联交所场内以每股均价7.2916港元买入长风药业(02652)H股2.51万股,涉资约18.30万港元,属场内主动交易,即在二级市场直接买卖股份。
梁文青此次增持前持有长风药业好仓6067.21万股,占比18.73%;增持后持股量为6069.72万股,好仓比例升至18.74%。
本次涉及关联方:苏州美中瑞投资管理企业(有限合伙)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.